TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.59B
AUM Growth
-$205M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1
+$42.1M
2
+$23.4M
3
+$21.4M
4
CELG
Celgene Corp
CELG
+$13.2M
5
SAGE
Sage Therapeutics
SAGE
+$11.2M

Top Sells

1
+$25.8M
2
+$23.6M
3
+$21.4M
4
GILD icon
Gilead Sciences
GILD
+$20.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$18.4M

Sector Composition

1 Healthcare 92.75%
2 Real Estate 2.87%
3 Financials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
151
$441K 0.02%
7,441
152
$438K 0.02%
20,000
153
$386K 0.01%
6,300
-70,300
154
$302K 0.01%
27,500
155
$300K 0.01%
7,053
156
$148K 0.01%
23,725
157
$61K ﹤0.01%
1,109
158
– –
-294,749
159
– –
-152,900
160
– –
-56,900
161
– –
-341,471
162
– –
-15,000
163
$0 ﹤0.01%
1
-50,444
164
– –
-48,076
165
– –
-1,034
166
– –
-123,200
3 4 5 6
7